Results 91 to 100 of about 13,923 (181)

Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis. [PDF]

Med Oncol
Farjami Z, Akbarin MM.
europepmc   +1 more source

The viral and host genomic landscape of human T-cell leukemia virus type I in Peru. [PDF]

Virol J
Enriquez-Vera D, Li J, Nakazaki-Aza J, Mochida K, Suzuki Y, Gotuzzo E, Montes M, Morishita K, Nakahata S.   +8 more
europepmc   +1 more source

Editorial: HTLV-1 and EBV-related disorders: pathogenesis and clinical advances. [PDF]

Front Med (Lausanne)
Miyashiro D, Casseb J, Sugaya M, Yasui H, Sanches JA.   +4 more
europepmc   +1 more source

Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c+ First Nations Cohort from Central Australia. [PDF]

Viruses
Grimley SL, Monard SC, Hirons A, Yap AHY, Collins S, Yurick D, Khoury G, Ellenberg PC, Pellegrini M, Einsiedel LJ, Purcell DFJ.   +10 more
europepmc   +1 more source

Clinical outcomes-dependent IgG epitope profiling in HTLV-1 reveals differential recognition of pathogen-derived antigens. [PDF]

Front Immunol
Cilento NE, Borges JVDS, Machado NR, do Nascimento LA, Moreira ALB, Passos LO, Santamarina AB, Casseb J, Sanabani SS, Victor JR.   +9 more
europepmc   +1 more source

Concurrent sigmoid colon adenocarcinoma presenting with cutaneous adult T-cell leukemia/lymphoma: a rare case report. [PDF]

Infect Agent Cancer
Maharati A, Zangooie A, Eydgahi MS, Haghshenas H, Eghbali Z, Meibodi NT, Salehi Z, Allahyari A.   +7 more
europepmc   +1 more source

Antenatal Screening for HTLV-1 and -2 Among Pregnant Women in Grenada: Combined Seroprevalence, Trends, and Public Health Implications (2015-2024). [PDF]

Viruses
Joseph SN, Richards C, Yakubu Y, Malur A, Frame T.   +4 more
europepmc   +1 more source

Rapidly Progressive and Relapsing Myelitis With Human T Lymphotropic Virus Type 1: A Case Report and Review of the Literature. [PDF]

Neurol Neuroimmunol Neuroinflamm
Morrison AA, Samudralwar RD, Berger JR.
europepmc   +1 more source

Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond. [PDF]

J Immunother Precis Oncol
Low SK, Fujiwara Y, Nishizaki D, Kato S, Kurzrock R.   +4 more
europepmc   +1 more source